DE3780770D1 - Therapeutisches gemisch aus einem faenger von freien radikalen oder einem stoffwechsel-hemmer und einem biologisch aktiven protein. - Google Patents

Therapeutisches gemisch aus einem faenger von freien radikalen oder einem stoffwechsel-hemmer und einem biologisch aktiven protein.

Info

Publication number
DE3780770D1
DE3780770D1 DE8787117149T DE3780770T DE3780770D1 DE 3780770 D1 DE3780770 D1 DE 3780770D1 DE 8787117149 T DE8787117149 T DE 8787117149T DE 3780770 T DE3780770 T DE 3780770T DE 3780770 D1 DE3780770 D1 DE 3780770D1
Authority
DE
Germany
Prior art keywords
scenner
biologically active
free radical
active protein
therapeutic mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787117149T
Other languages
English (en)
Other versions
DE3780770T2 (de
Inventor
Robert Zimmermann
Marafino, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Application granted granted Critical
Publication of DE3780770D1 publication Critical patent/DE3780770D1/de
Publication of DE3780770T2 publication Critical patent/DE3780770T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8787117149T 1986-11-21 1987-11-20 Therapeutisches gemisch aus einem faenger von freien radikalen oder einem stoffwechsel-hemmer und einem biologisch aktiven protein. Expired - Fee Related DE3780770T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93347586A 1986-11-21 1986-11-21
US11364387A 1987-10-26 1987-10-26

Publications (2)

Publication Number Publication Date
DE3780770D1 true DE3780770D1 (de) 1992-09-03
DE3780770T2 DE3780770T2 (de) 1993-02-25

Family

ID=26811304

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787117149T Expired - Fee Related DE3780770T2 (de) 1986-11-21 1987-11-20 Therapeutisches gemisch aus einem faenger von freien radikalen oder einem stoffwechsel-hemmer und einem biologisch aktiven protein.

Country Status (5)

Country Link
EP (1) EP0269017B1 (de)
CA (1) CA1321349C (de)
DE (1) DE3780770T2 (de)
ES (1) ES2042529T4 (de)
GR (1) GR3005314T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
US5523077A (en) * 1992-02-06 1996-06-04 Yale University Composition and method for whitening skin
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
DE69330285D1 (de) * 1993-03-10 2001-07-05 Univ Yale New Haven Mittel und verfahren zur bleichung der haut
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
WO1995024894A2 (en) * 1994-03-14 1995-09-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
KR20010072957A (ko) * 1998-08-24 2001-07-31 추후보정 Ｈ2 수용체 작용제 및 기타 ｔ-세포 활성화제를 사용한ｔ-세포(ｃｄ4+ 및 ｃｄ8+) 활성화 및 보호 방법
US20190070247A1 (en) 2017-09-07 2019-03-07 The Children's Hospital Of Philadelphia Compositions and Methods for Treatment of Hereditary Cystatin C Amyloid Angiopathy (HCCAA) and Other Neurodegenerative Disorders Associated with Aberrant Amyloid Deposits

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526205A (en) * 1974-11-07 1978-09-27 Searle & Co Treatment of interferon-like material
EP0177342A3 (de) * 1984-10-04 1987-12-02 Genentech, Inc. Orale Formulierungen therapeutischer Proteine

Also Published As

Publication number Publication date
EP0269017A2 (de) 1988-06-01
ES2042529T3 (es) 1993-12-16
GR3005314T3 (de) 1993-05-24
EP0269017A3 (en) 1989-06-21
DE3780770T2 (de) 1993-02-25
CA1321349C (en) 1993-08-17
ES2042529T4 (es) 1996-07-16
JPS63190831A (ja) 1988-08-08
EP0269017B1 (de) 1992-07-29

Similar Documents

Publication Publication Date Title
NO861955L (no) Hydrolyserbar harpiksblanding og et antibegroningsbelegg inneholdende dette:
DK567486D0 (da) Gummiblanding og dens anvendelse
MX174467B (es) 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
DE3650101D1 (de) Analoga von Insulin und deren Herstellungsmethode.
KR890700204A (ko) 패킹재료 및 이것을 사용한 패킹
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
DE3764926D1 (de) Schaedlingsbekaempfungs- und pflanzenbehandlungsmittel.
DK381388D0 (da) Middel med mikrobicid virkning indeholdende iod og lactoperoxidase
DK150986D0 (da) Hydroxamater med lipoxygenase-inhiberende virkning og terapeutiske midler indeholdende saadanne forbindelser
DE3685626D1 (de) Sequenzierung von peptiden.
DK47285A (da) Renininhiberende peptider og anvendelsen deraf
DK506385A (da) Kaeledyrsfoder og bestanddel deraf
DK165233C (da) Doseringsventil
DK232386A (da) Fraebehandling
GB2177919B (en) Synergistic biologically active substances
DE3780770D1 (de) Therapeutisches gemisch aus einem faenger von freien radikalen oder einem stoffwechsel-hemmer und einem biologisch aktiven protein.
DK403384A (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
TR25479A (tr) Hasereleri ve kurtcuklari kovmaya mahsus maddeler
FR2611069B1 (fr) Calendrier posologique
DK109590D0 (da) Biologisk aktivt protein
DK104186A (da) 2,3,4-triacylhexoser og blandinger deraf
ATE78700T1 (de) Therapeutisches gemisch aus einem faenger von freien radikalen oder einem stoffwechsel-hemmer und einem biologisch aktiven protein.
DE3675720D1 (de) Behandlung von material aus lignocellulose.
DE3577985D1 (de) Organotitan-verbindungen und oberflaechenbehandlungsmittel.
DE3673072D1 (de) Behandlung von lignocellulosematerialien.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CHIRON CORP. (N.D.GES.D. STAATES DELAWARE), EMERYV

8339 Ceased/non-payment of the annual fee